L1000FWD
Large Scale Visualization of Drug
Induced Transcriptomic Signatures
Map
All cell lines
BT20 (kNN)
THP1 (tSNE)
NPC (tSNE)
HT29 (tSNE)
A549 (kNN)
A375 (kNN)
A375 (tSNE)
HCC515 (tSNE)
MDAMB231 (kNN)
HEPG2 (tSNE)
HCC515 (kNN)
MDAMB231 (tSNE)
NEU (tSNE)
SKB (tSNE)
A549 (tSNE)
SKBR3 (kNN)
HA1E (kNN)
MCF10A (tSNE)
ASC (kNN)
VCAP (kNN)
HT29 (kNN)
BT20 (tSNE)
VCAP (tSNE)
MCF7 (kNN)
THP1 (kNN)
ASC (tSNE)
MCF10A (kNN)
NEU (kNN)
PC3 (tSNE)
HA1E (tSNE)
SKB (kNN)
NPC (kNN)
SKBR3 (tSNE)
MCF7 (tSNE)
HS578T (tSNE)
PHH (tSNE)
PHH (kNN)
PC3 (kNN)
HS578T (kNN)
HEPG2 (kNN)
Drugs
Signatures
Download
API
Signature Report
Signature ID
CPC014_SKB_24H:BRD-M16762496-001-01-9:10
Cell Line
SKB
Dose
10.0 μM
Time
24 hours
p-value
< 0.0001
Drug Name
PIK-75
External Links and Downloads
Up (240)
Down (236)
Combined (475)
Gene lists
Submit for Analysis with Enrichr
PIK-75 (BRD-M16762496)
Overview
pert_id
BRD-M16762496
Name
PIK-75
Synonyms
S1205
Collection
BIOA
Summary
PIK-75 is a selective and competitive inhibitor of p110α with IC50 of 5.8 nM and also potently inhibits DNA-PK with IC50 of 2 nM.
MOA
DNA protein kinase inhibitor, PI3K inhibitor
Target(s)
PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC
Indication(s)
Unknown
Phase
Preclinical
Canonical SMILES
CI.CN(N=Cc1cnc2ccc(Br)cn12)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O
InChI key
InChIKey=HFUAOBLWRUIXKP-MYHMWQFYSA-N
InChI string
InChI=1S/C16H14BrN5O4S.CH3I/c1-11-3-5-13(22(23)24)7-15(11)27(25,26)20(2)19-9-14-8-18-16-6-4-12(17)10-21(14)16;1-2/h3-10H,1-2H3;1H3/b19-9+;
Molecular formula
C17H17BrIN5O4S
Molecular weight
594.221
External links
PubChem
73707389
Wikipedia
https://www.caymanchem.com/app/template/Product.vm/catalog/10009210
SEP-L1000
BRD-M16762496
Predicted MOAs
MOA
Probability
cyclooxygenase inhibitor
0.2576
CDK inhibitor
0.1682
calcium channel blocker
0.1625
MEK inhibitor
0.1095
PI3K inhibitor
0.0829
HDAC inhibitor
0.0400
RAF inhibitor
0.0296
EGFR inhibitor
0.0235
histamine receptor antagonist
0.0223
HSP inhibitor
0.0220
Chemical structure